Temas de Pediatria - Nestlé

Temas de Pediatria nº 90
AR-Bed(R)” in 3 weeks – 3 month old infants on
regurgitation, associated symptoms andacid refl
ux. Arch Dis Child 2010;95:26–30.
36. Horwath A, Dzierchciarz P, Szajewska H. The
effect of thickened feed interventions on gastroesophageal
reflux in infants: systematic review
and meta-analysis of randomized, control trials.
Pediatrics 2008;122:e1268-e1277.
37. Bosscher D, Van Caillie-Bertrand M, Deelstra H.
Do thickening properties of locust bean gum affect
the amount of calcium, iron and zinc available for
absorption from infant formula In vitro studies.
Int J Food Sci Nutr 2003;54:261–832.
38. Chao H, Vandenplas Y. Effect of cereal-thicekned
formula and upright positioning on regurgitation,
gastric emptying and weight gain in infants with
regurgitation. Nutrition 2007; 23(1): 23-8.
39. Wenzl TG, Schneider S, Scheele F, Silny J, Heimann
G, Skopnik H. Effects of thickene feeding
on gastroesophageal reflux in infants: a placebocontrolled
crossover study using intraluminal
impedance. Pediatrics. 2003; 111(4): e355-9.
40. Iacono G, Carroccio A, Cavataio F, et al. Gastroesophageal
reflux and cow’s milk allergy in
infants: a prospective study. J Allergy Clin Immunol
1996;97:822–7.
41. Nielsen RG, Bindslev-Jensen C, Kruse-Andersen,
S, Husby S. Severe Gastroesophageal Reflux
Disease and Cow Milk Hypersensitivity in Infants
and Children: Disease Associatio and Evaluation
of a New Challenge Procedure. JPGN 2004; 39(4):
383-91.
42. Kaltenbach T, Crickett S, Gerson LB. Are lifestyle
measures effective in patients with gastroesophageal
reflux disease An evidence-based approach.
Arch Intern Med. 2006 May 8;166(9):965-71.
43. Salvatore S, Hauser B, Salvatoni A, Vandenplas Y.
Oral ranitidine and duration of gastric pH > 4.0
in infants with persisting reflux-symptoms. Acta
Paediatr. 2006 Feb;95(2):176-81.
44. Barron JJ, Tan H, Spalding J, et al. Proton pump
inhibitor utilization patterns in infants. J Pediatr
Gastroenterol Nutr 2007;45:421–7.
45. Omari T, Haslam R, Lundborg P, Davidson, G.
Effect of Omeprazole on Acid Gastroesophageal
Reflux and Gastric Acidity in Preterm Infants With
Pathological Acid Reflux. JPGN 2007;44(1):41-44.
46. Canani RB, Cirillo P, Roggero P, et al. Therapy with
gastric acidity inhibitors increases the risk of acute
gastroenteritis and community-acquired pneumonia
in children. Pediatrics 2006;117:e817–20.
47. Guillet R, Stoll BJ, Cotten CM, et al. Association
of H2-blocker therapy and higher incidence of
necrotizing enterocolitis in very low birth weight
infants. Pediatrics 2006;117:e137–42.
48. Gremse D, Winter H, Tolia V, et al. Pharmacokinetics
and pharmacodynamics of lansoprazole
in children with gastroesophageal reflux disease.
J Pediatr Gastroenterol Nutr 2002;35(Suppl
4):S319–26.
49. Zhao J, Li J, Hamer-Maansson JE, et al. Pharmacokinetic
properties of esomeprazole in children aged
1 to 11 years with symptoms of gastroesophageal
reflux disease: a randomized, open-label study.
Clin Ther 2006;28:1868–76.
50. Tounian P. Gastroesophageal reflux treatment:
From therapeutic abstention to surgery. Arch Ped
2009:16;1424-28.
51. Winter HS. Gastroesophageal reflux in infants.
www.uptodate.com (2010):1-12.
52. Keady S. Update on drugs for gastro-oesophageal
reflux disease. Arch Dis Child Educ Pract Ed.
2007 Aug;92(4):ep114-8.
53. Hibbs AM, Lorch SA. Metoclopramide for the
treatment of gastroesophagel reflux disease in
infants a systematic review. Pediatrics. 2006
Aug;118(2):746-52.
54. Lee SL, Sydorak RM, Chiu VY, Hsu JW, Applebaum
H, Haigh PI. Long-term antireflux medication use
following pediatric Nissen fundoplication. Arch
Surg. 2008 Sep;143(9):873-6.
Nestlé Nutrition Institute
23